Rationale and design of repeated cross-sectional studies to evaluate the reporting quality of trial protocols: the Adherence to SPIrit REcommendations (ASPIRE) study and associated projects

Dmitry Gryaznov; Ayodele Odutayo; Belinda von Niederhäusern; Benjamin Speich; Benjamin Kasenda; Elena Ojeda-Ruiz; Anette Blümle; Stefan Schandelmaier; Dominik Mertz; Yuki Tomonaga; Alain Amstutz; Christiane Pauli-Magnus; Viktoria Gloy; Karin Bischoff; Katharina Wollmann; Laura Rehner; Szimonetta Lohner; Joerg J. Meerpohl; Alain Nordmann; Katharina Klatte; Nilabh Ghosh; Ala Taji Heravi; Jacqueline Wong; Ngai Chow; Patrick Jiho Hong; Kimberly Mc Cord; Sirintip Sricharoenchai; Jason W. Busse; Arnav Agarwal; Ramon Saccilotto; Matthias Schwenkglenks; Giusi Moffa; Lars G. Hemkens; Sally Hopewell; Erik von Elm; Matthias Briel

doi:10.1186/s13063-020-04808-y

Trials (Oct 2020)

Rationale and design of repeated cross-sectional studies to evaluate the reporting quality of trial protocols: the Adherence to SPIrit REcommendations (ASPIRE) study and associated projects

Dmitry Gryaznov,
Ayodele Odutayo,
Belinda von Niederhäusern,
Benjamin Speich,
Benjamin Kasenda,
Elena Ojeda-Ruiz,
Anette Blümle,
Stefan Schandelmaier,
Dominik Mertz,
Yuki Tomonaga,
Alain Amstutz,
Christiane Pauli-Magnus,
Viktoria Gloy,
Karin Bischoff,
Katharina Wollmann,
Laura Rehner,
Szimonetta Lohner,
Joerg J. Meerpohl,
Alain Nordmann,
Katharina Klatte,
Nilabh Ghosh,
Ala Taji Heravi,
Jacqueline Wong,
Ngai Chow,
Patrick Jiho Hong,
Kimberly Mc Cord,
Sirintip Sricharoenchai,
Jason W. Busse,
Arnav Agarwal,
Ramon Saccilotto,
Matthias Schwenkglenks,
Giusi Moffa,
Lars G. Hemkens,
Sally Hopewell,
Erik von Elm,
Matthias Briel

Affiliations

Dmitry Gryaznov: Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel and University of Basel
Ayodele Odutayo: Applied Health Research Centre, Li Ka Shing Knowledge Instiute of St Michael’s Hospital
Belinda von Niederhäusern: Department of Clinical Research, Clinical Trial Unit, University Hospital Basel and University of Basel
Benjamin Speich: Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel and University of Basel
Benjamin Kasenda: Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel and University of Basel
Elena Ojeda-Ruiz: Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel and University of Basel
Anette Blümle: Institute for Evidence in Medicine, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg
Stefan Schandelmaier: Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel and University of Basel
Dominik Mertz: Department of Health Research Methods, Evidence, and Impact, McMaster University
Yuki Tomonaga: Epidemiology, Biostatistics and Prevention Institute, University of Zurich
Alain Amstutz: Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel and University of Basel
Christiane Pauli-Magnus: Department of Clinical Research, Clinical Trial Unit, University Hospital Basel and University of Basel
Viktoria Gloy: Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel and University of Basel
Karin Bischoff: Institute for Evidence in Medicine, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg
Katharina Wollmann: Institute for Evidence in Medicine, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg
Laura Rehner: Institute for Evidence in Medicine, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg
Szimonetta Lohner: Cochrane Hungary, Clinical Centre of the University of Pécs, Medical School, University of Pécs
Joerg J. Meerpohl: Institute for Evidence in Medicine, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg
Alain Nordmann: Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel and University of Basel
Katharina Klatte: Department of Clinical Research, Clinical Trial Unit, University Hospital Basel and University of Basel
Nilabh Ghosh: Department of Neurosurgery and Department of Biomedicine, University Hospital Basel, University of Basel
Ala Taji Heravi: Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel and University of Basel
Jacqueline Wong: Department of Health Research Methods, Evidence, and Impact, McMaster University
Ngai Chow: Department of Health Research Methods, Evidence, and Impact, McMaster University
Patrick Jiho Hong: Department of Health Research Methods, Evidence, and Impact, McMaster University
Kimberly Mc Cord: Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel and University of Basel
Sirintip Sricharoenchai: Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel and University of Basel
Jason W. Busse: Department of Health Research Methods, Evidence, and Impact, McMaster University
Arnav Agarwal: Department of Health Research Methods, Evidence, and Impact, McMaster University
Ramon Saccilotto: Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel and University of Basel
Matthias Schwenkglenks: Epidemiology, Biostatistics and Prevention Institute, University of Zurich
Giusi Moffa: Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel and University of Basel
Lars G. Hemkens: Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel and University of Basel
Sally Hopewell: Oxford Clinical Trials Research Unit and Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
Erik von Elm: Cochrane Switzerland, Centre for Primary Care and Public Health (Unisanté), University of Lausanne
Matthias Briel: Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel and University of Basel

DOI: https://doi.org/10.1186/s13063-020-04808-y
Journal volume & issue: Vol. 21, no. 1
pp. 1 – 13

Abstract

Read online

Abstract Background Clearly structured and comprehensive protocols are an essential component to ensure safety of participants, data validity, successful conduct, and credibility of results of randomized clinical trials (RCTs). Funding agencies, research ethics committees (RECs), regulatory agencies, medical journals, systematic reviewers, and other stakeholders rely on protocols to appraise the conduct and reporting of RCTs. In response to evidence of poor protocol quality, the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) guideline was published in 2013 to improve the accuracy and completeness of clinical trial protocols. The impact of these recommendations on protocol completeness and associations between protocol completeness and successful RCT conduct and publication remain uncertain. Objectives and methods Aims of the Adherence to SPIrit REcommendations (ASPIRE) study are to investigate adherence to SPIRIT checklist items of RCT protocols approved by RECs in the UK, Switzerland, Germany, and Canada before (2012) and after (2016) the publication of the SPIRIT guidelines; determine protocol features associated with non-adherence to SPIRIT checklist items; and assess potential differences in adherence across countries. We assembled an international cohort of RCTs based on 450 protocols approved in 2012 and 402 protocols approved in 2016 by RECs in Switzerland, the UK, Germany, and Canada. We will extract data on RCT characteristics and adherence to SPIRIT for all included protocols. We will use multivariable regression models to investigate temporal changes in SPIRIT adherence, differences across countries, and associations between SPIRIT adherence of protocols with RCT registration, completion, and publication of results. We plan substudies to examine the registration, premature discontinuation, and non-publication of RCTs; the use of patient-reported outcomes in RCT protocols; SPIRIT adherence of RCT protocols with non-regulated interventions; the planning of RCT subgroup analyses; and the use of routinely collected data for RCTs. Discussion The ASPIRE study and associated substudies will provide important information on the impact of measures to improve the reporting of RCT protocols and on multiple aspects of RCT design, trial registration, premature discontinuation, and non-publication of RCTs observing potential changes over time.

Published in Trials

ISSN: 1745-6215 (Online)
Publisher: BMC
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: https://trialsjournal.biomedcentral.com

About the journal

Abstract

Keywords